secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2022-04-06T23:59:59+00:00
Accession:  0001104659-22-043015
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Collegium appoints Neil F. McFarlane to board; expands to nine directors
------------------------------------------------------------------------

- Board expanded from 8 to 9 members; McFarlane appointed effective April 6, 2022.
- Appointed director Neil F. McFarlane, 49, initial term until May 19, 2022 annual meeting.
- Annual cash retainer of $50k prorated; RSUs with grant date value of $337,500 vesting one year from grant.
- No family relationships or reportable related party transactions with existing directors/officers.
- No arrangement with any other person for selection as director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465922043015/0001104659-22-043015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465922043015/tm2211650d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-043015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer